Agrinue: plant-based lipid carriers for enhanced nitrogen use efficiency

Technology
In development
University

AgriNUE uses plant-based lipids to create biodegradable carriers for nitrogen fertilizers, improving nutrient delivery and uptake. This approach reduces toxicity and regulatory concerns while enhancing scalability and cost-effectiveness.

Overview

AgriNUE represents a novel approach to enhancing nitrogen use efficiency in agriculture by leveraging plant-based lipid carriers. This technology adapts the liposomal drug delivery system from the medical field to agriculture, encapsulating nitrogen fertilizers within biodegradable particles. This method improves nutrient delivery precision, controlled release, and uptake efficiency compared to traditional fertilizers. The use of food-grade plant lipids reduces toxicity risks and regulatory barriers, while also lowering production costs and facilitating integration into existing fertilizer products.

Technical specifications

Key features:

  • Utilizes plant-based lipids to encapsulate nitrogen fertilizers such as nitrate and urea.
  • Employs a continuous, scalable production process to tune particle size and encapsulation efficiency.
  • Reduces nitrogen losses by localizing nutrients in the root zone and enabling gradual release.
  • Compatible with existing fertilizer products and capable of co-formulating with other agrochemicals like nitrification or urease inhibitors.
Technology readiness level

AgriNUE is currently at Technology Readiness Level 5, having demonstrated its efficacy in controlled environments. The technology is poised for further development and commercialization through strategic partnerships focused on large-scale production and agronomic validation under real-world farming conditions.


About University of Pittsburgh

The University of Pittsburgh is a large, comprehensive public research university anchored in an urban innovation corridor with a strong translational focus. Integration with UPMC, a leading academic medical center, enables clinical studies, access to broad patient populations, and co-located clinical–engineering labs that shorten paths from discovery to deployment. A nearby research and technology district, extensive core facilities, and an engineering co-op program give companies entry points for prototyping and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DoD, and DOE. A dedicated technology transfer office provides IP strategy, licensing, startup support, and contracting for industry partners.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.